Active Ingredient: BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Proprietary Name: CASSIPA
Dosage Form; Route of Administration: FILM; SUBLINGUAL
Strength: EQ 16MG BASE;EQ 4MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N208042
Product Number: 001
Approval Date: Sep 7, 2018
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
